CCLA Investment Management Purchases 9,178 Shares of Agilent Technologies, Inc. (NYSE:A)

CCLA Investment Management grew its position in shares of Agilent Technologies, Inc. (NYSE:A) by 1.2% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 782,917 shares of the medical research company’s stock after purchasing an additional 9,178 shares during the quarter. CCLA Investment Management owned about 0.27% of Agilent Technologies worth $102,253,000 as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. Vanguard Group Inc. increased its stake in shares of Agilent Technologies by 18.2% in the 1st quarter. Vanguard Group Inc. now owns 29,884,345 shares of the medical research company’s stock valued at $4,348,471,000 after acquiring an additional 4,605,228 shares in the last quarter. Massachusetts Financial Services Co. MA increased its stake in shares of Agilent Technologies by 5.7% in the 2nd quarter. Massachusetts Financial Services Co. MA now owns 15,064,660 shares of the medical research company’s stock valued at $1,952,832,000 after acquiring an additional 809,149 shares in the last quarter. Price T Rowe Associates Inc. MD increased its stake in shares of Agilent Technologies by 13.9% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 8,542,054 shares of the medical research company’s stock valued at $1,242,956,000 after acquiring an additional 1,042,926 shares in the last quarter. Van ECK Associates Corp increased its stake in shares of Agilent Technologies by 0.7% in the 2nd quarter. Van ECK Associates Corp now owns 2,793,189 shares of the medical research company’s stock valued at $362,081,000 after acquiring an additional 18,205 shares in the last quarter. Finally, Nordea Investment Management AB increased its stake in shares of Agilent Technologies by 4.4% in the 1st quarter. Nordea Investment Management AB now owns 2,783,238 shares of the medical research company’s stock valued at $406,715,000 after acquiring an additional 116,822 shares in the last quarter. Institutional investors own 87.42% of the company’s stock.

Insider Transactions at Agilent Technologies

In other news, CEO Padraig Mcdonnell sold 1,958 shares of Agilent Technologies stock in a transaction on Thursday, August 22nd. The stock was sold at an average price of $145.00, for a total transaction of $283,910.00. Following the sale, the chief executive officer now directly owns 24,118 shares in the company, valued at approximately $3,497,110. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 0.33% of the company’s stock.

Wall Street Analysts Forecast Growth

A has been the subject of several research analyst reports. Jefferies Financial Group reiterated a “hold” rating and issued a $135.00 price objective (down previously from $152.00) on shares of Agilent Technologies in a research note on Monday, June 3rd. Wells Fargo & Company began coverage on shares of Agilent Technologies in a research note on Tuesday, August 27th. They issued an “overweight” rating and a $157.00 price objective for the company. Citigroup lifted their price target on shares of Agilent Technologies from $150.00 to $165.00 and gave the company a “buy” rating in a research report on Thursday, August 22nd. JPMorgan Chase & Co. reduced their price target on shares of Agilent Technologies from $165.00 to $155.00 and set an “overweight” rating for the company in a research report on Thursday, May 30th. Finally, Stifel Nicolaus reissued a “buy” rating and issued a $151.00 price target on shares of Agilent Technologies in a research report on Monday, August 26th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and nine have assigned a buy rating to the company’s stock. According to MarketBeat, Agilent Technologies has an average rating of “Moderate Buy” and a consensus target price of $141.60.

Agilent Technologies Price Performance

A opened at $138.35 on Wednesday. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.78 and a quick ratio of 1.37. The company has a market capitalization of $40.37 billion, a price-to-earnings ratio of 32.71, a P/E/G ratio of 6.43 and a beta of 1.05. The firm’s fifty day moving average price is $137.26 and its two-hundred day moving average price is $139.25. Agilent Technologies, Inc. has a 1 year low of $96.80 and a 1 year high of $155.35.

Agilent Technologies (NYSE:A) last released its earnings results on Wednesday, August 21st. The medical research company reported $1.32 EPS for the quarter, topping analysts’ consensus estimates of $1.26 by $0.06. The company had revenue of $1.58 billion for the quarter, compared to analysts’ expectations of $1.56 billion. Agilent Technologies had a return on equity of 25.26% and a net margin of 21.75%. The business’s revenue for the quarter was down 5.6% compared to the same quarter last year. During the same period in the previous year, the business posted $1.43 EPS. As a group, analysts anticipate that Agilent Technologies, Inc. will post 5.24 earnings per share for the current fiscal year.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.